Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-020389
Filing Date
2022-08-12
Accepted
2022-08-12 17:01:25
Documents
53
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q mbrx20220630_10q.htm   iXBRL 10-Q 834174
2 EXHIBIT 31.1 ex_377899.htm EX-31.1 13420
3 EXHIBIT 31.2 ex_377900.htm EX-31.2 13253
4 EXHIBIT 32.1 ex_377901.htm EX-32.1 6694
5 EXHIBIT 32.2 ex_377902.htm EX-32.2 6778
11 moleculinnewlogoresized.jpg GRAPHIC 7783
  Complete submission text file 0001437749-22-020389.txt   3864761

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mbrx-20220630.xsd EX-101.SCH 42093
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mbrx-20220630_cal.xml EX-101.CAL 30076
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mbrx-20220630_def.xml EX-101.DEF 233108
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mbrx-20220630_lab.xml EX-101.LAB 229038
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mbrx-20220630_pre.xml EX-101.PRE 255182
47 EXTRACTED XBRL INSTANCE DOCUMENT mbrx20220630_10q_htm.xml XML 550564
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671999 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37758 | Film No.: 221161048
SIC: 2834 Pharmaceutical Preparations